Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291135 · ClinicalTrials.gov registry record · Phase 2
Protocol for Women at Increased Risk of Developing Breast Cancer
A Phase 2 study, sponsored by Carol Fabian, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
NCT00291135 is a Phase 2 study that has completed, run by Carol Fabian, MD. The registered enrollment target is 42 participants.
The verdict
NCT00291135, a Phase 2 study, has completed, sponsored by Carol Fabian, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
Study Summary
A pilot study to assess the effects of six months of letrozole on breast tissue risk markers in postmenopausal women on hormone replacement therapy at high risk of developing breast cancer.
Interventions
- DRUG letrozole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00291135
The ClinicalTrials.gov registry entry for NCT00291135 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carol Fabian, MD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which letrozole is the first listed.
NCT00291135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00291135 about?
NCT00291135 is a clinical study titled "Protocol for Women at Increased Risk of Developing Breast Cancer". A pilot study to assess the effects of six months of letrozole on breast tissue risk markers in postmenopausal women on hormone replacement therapy at high risk of developing breast cancer.
What is the current status of trial NCT00291135?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2003-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00291135?
The interventions under investigation include: letrozole (DRUG).
Who is sponsoring clinical trial NCT00291135?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.